Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
Five-year analysis of the prevention of colorectal sporadic adenomatous polyps trial. [electronic resource] by
- Arber, Nadir
- Spicak, Julius
- Rácz, István
- Zavoral, Miroslav
- Breazna, Aurora
- Gerletti, Paola
- Lechuga, Maria J
- Collins, Neal
- Rosenstein, Rebecca B
- Eagle, Craig J
- Levin, Bernard
Producer: 20110812
In:
The American journal of gastroenterology vol. 106
Availability: No items available.
|
|
12.
|
Phase I study of sunitinib plus modified FOLFOX6 in Japanese patients with treatment-naive colorectal cancer. [electronic resource] by
- Yoshino, Takayuki
- Yamazaki, Kentaro
- Hamaguchi, Tetsuya
- Shimada, Yasuhiro
- Kato, Ken
- Yasui, Hirofumi
- Boku, Narikazu
- Lechuga, Maria Jose
- Hirohashi, Tomoko
- Shibata, Atsushi
- Hashigaki, Satoshi
- Li, Yinhua
- Ohtsu, Atsushi
Producer: 20120508
In:
Anticancer research vol. 32
Availability: No items available.
|
|
13.
|
|
|
14.
|
First-line sunitinib plus FOLFIRI in Japanese patients with unresectable/metastatic colorectal cancer: a phase II study. [electronic resource] by
- Tsuji, Yasushi
- Satoh, Taroh
- Tsuji, Akihito
- Muro, Kei
- Yoshida, Motoki
- Nishina, Tomohiro
- Nagase, Michitaka
- Komatsu, Yoshito
- Kato, Takeshi
- Miyata, Yoshinori
- Mizutani, Naoko
- Hashigaki, Satoshi
- Lechuga, Maria Jose
- Denda, Tadamichi
Producer: 20130507
In:
Cancer science vol. 103
Availability: No items available.
|
|
15.
|
Mechanism-related circulating proteins as biomarkers for clinical outcome in patients with unresectable hepatocellular carcinoma receiving sunitinib. [electronic resource] by
- Harmon, Charles S
- DePrimo, Samuel E
- Raymond, Eric
- Cheng, Ann-Lii
- Boucher, Eveline
- Douillard, Jean-Yves
- Lim, Ho Y
- Kim, Jun S
- Lechuga, Maria José
- Lanzalone, Silvana
- Lin, Xun
- Faivre, Sandrine
Producer: 20111122
In:
Journal of translational medicine vol. 9
Availability: No items available.
|
|
16.
|
Regional Differences in Efficacy, Safety, and Biomarkers for Second-Line Axitinib in Patients with Advanced Hepatocellular Carcinoma: From a Randomized Phase II Study. [electronic resource] by
- Kudo, Masatoshi
- Kang, Yoon-Koo
- Park, Joong-Won
- Qin, Shukui
- Inaba, Yoshitaka
- Assenat, Eric
- Umeyama, Yoshiko
- Lechuga, Maria José
- Valota, Olga
- Fujii, Yosuke
- Martini, Jean-Francois
- Williams, J Andrew
- Obi, Shuntaro
Publication details: Liver cancer May 2018
In:
Liver cancer vol. 7
Availability: No items available.
|
|
17.
|
Safety and efficacy of sunitinib in patients with advanced hepatocellular carcinoma: an open-label, multicentre, phase II study. [electronic resource] by
- Faivre, Sandrine
- Raymond, Eric
- Boucher, Eveline
- Douillard, Jean
- Lim, Ho Y
- Kim, Jun S
- Zappa, Magaly
- Lanzalone, Silvana
- Lin, Xun
- Deprimo, Samuel
- Harmon, Charles
- Ruiz-Garcia, Ana
- Lechuga, Maria J
- Cheng, Ann Lii
Producer: 20090909
In:
The Lancet. Oncology vol. 10
Availability: No items available.
|
|
18.
|
A synthetic peptide from transforming growth factor beta type III receptor inhibits liver fibrogenesis in rats with carbon tetrachloride liver injury. [electronic resource] by
- Ezquerro, Ignacio-José
- Lasarte, Juan-José
- Dotor, Javier
- Castilla-Cortázar, Inma
- Bustos, Matilde
- Peñuelas, Iván
- Blanco, Gemma
- Rodríguez, Carlos
- Lechuga, Maria del Carmen G
- Greenwel, Patricia
- Rojkind, Marcos
- Prieto, Jesús
- Borrás-Cuesta, Francisco
Producer: 20040315
In:
Cytokine vol. 22
Availability: No items available.
|
|
19.
|
Immune Biomarkers Predictive for Disease-Free Survival with Adjuvant Sunitinib in High-Risk Locoregional Renal Cell Carcinoma: From Randomized Phase III S-TRAC Study. [electronic resource] by
- George, Daniel J
- Martini, Jean-François
- Staehler, Michael
- Motzer, Robert J
- Magheli, Ahmed
- Escudier, Bernard
- Gerletti, Paola
- Li, Sherry
- Casey, Michelle
- Laguerre, Brigitte
- Pandha, Hardev S
- Pantuck, Allan J
- Patel, Anup
- Lechuga, Maria J
- Ravaud, Alain
Producer: 20190927
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 24
Availability: No items available.
|
|
20.
|
A Phase Ib Study of Axitinib in Combination with Crizotinib in Patients with Metastatic Renal Cell Cancer or Other Advanced Solid Tumors. [electronic resource] by
- Michaelson, M Dror
- Gupta, Shilpa
- Agarwal, Neeraj
- Szmulewitz, Russell
- Powles, Thomas
- Pili, Roberto
- Bruce, Justine Yang
- Vaishampayan, Ulka
- Larkin, James
- Rosbrook, Brad
- Wang, Erjian
- Murphy, Danielle
- Wang, Panpan
- Lechuga, Maria Josè
- Valota, Olga
- Shepard, Dale R
Producer: 20200727
In:
The oncologist vol. 24
Availability: No items available.
|